A fundamental basis for this approach, then, is to identify when Dyrk1a is overexpressed in specific tissues at defined ages in trisomic mice, some of which may represent sensitive periods of developmental vulnerability that yield long‐lasting DS structural and functional phenotypes. The gene discussed is DYRK1A; the disease is Dravet syndrome.